These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


318 related items for PubMed ID: 16153393

  • 1. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
    Magnusson Y, Levin MC, Eggertsen R, Nyström E, Mobini R, Schaufelberger M, Andersson B.
    Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
    [Abstract] [Full Text] [Related]

  • 2. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
    Biolo A, Clausell N, Santos KG, Salvaro R, Ashton-Prolla P, Borges A, Rohde LE.
    Am J Cardiol; 2008 Sep 15; 102(6):726-32. PubMed ID: 18773997
    [Abstract] [Full Text] [Related]

  • 3. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
    Schwartz SG, Puckett BJ, Allen RC, Castillo IG, Leffler CT.
    Ophthalmology; 2005 Dec 15; 112(12):2131-6. PubMed ID: 16325708
    [Abstract] [Full Text] [Related]

  • 4. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
    Forleo C, Sorrentino S, Guida P, Romito R, De Tommasi E, Iacoviello M, Pitzalis M.
    J Cardiovasc Med (Hagerstown); 2007 Aug 15; 8(8):589-95. PubMed ID: 17667029
    [Abstract] [Full Text] [Related]

  • 5. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
    Forleo C, Resta N, Sorrentino S, Guida P, Manghisi A, De Luca V, Romito R, Iacoviello M, De Tommasi E, Troisi F, Rizzon B, Guanti G, Rizzon P, Pitzalis MV.
    Am J Med; 2004 Oct 01; 117(7):451-8. PubMed ID: 15464701
    [Abstract] [Full Text] [Related]

  • 6. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
    Terra SG, Pauly DF, Lee CR, Patterson JH, Adams KF, Schofield RS, Belgado BS, Hamilton KK, Aranda JM, Hill JA, Yarandi HN, Walker JR, Phillips MS, Gelfand CA, Johnson JA.
    Clin Pharmacol Ther; 2005 Mar 01; 77(3):127-37. PubMed ID: 15735607
    [Abstract] [Full Text] [Related]

  • 7. Polymorphisms of norepinephrine transporter and adrenergic receptor alpha1D are associated with the response to beta-blockers in dilated cardiomyopathy.
    Nonen S, Okamoto H, Fujio Y, Takemoto Y, Yoshiyama M, Hamaguchi T, Matsui Y, Yoshikawa J, Kitabatake A, Azuma J.
    Pharmacogenomics J; 2008 Feb 01; 8(1):78-84. PubMed ID: 17404580
    [Abstract] [Full Text] [Related]

  • 8. A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy.
    Herrmann S, Schmidt-Petersen K, Pfeifer J, Perrot A, Bit-Avragim N, Eichhorn C, Dietz R, Kreutz R, Paul M, Osterziel KJ.
    Eur Heart J; 2001 Oct 01; 22(20):1948-53. PubMed ID: 11601839
    [Abstract] [Full Text] [Related]

  • 9. Cardiac reserve in the transplanted heart: effect of a graft polymorphism in the beta1-adrenoceptor.
    Scharin Täng M, Lindberg E, Grüner Sveälv B, Magnusson Y, Andersson B.
    J Heart Lung Transplant; 2007 Sep 01; 26(9):915-20. PubMed ID: 17845930
    [Abstract] [Full Text] [Related]

  • 10. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
    Paczkowska A, Szperl M, Małek Ł, Mazurkiewicz Ł, Skóra E, Grzybowski J, Roszczynko M, Bilińska Z, Tesson F, Ruzyłło W.
    Kardiol Pol; 2009 Mar 01; 67(3):235-41. PubMed ID: 19378229
    [Abstract] [Full Text] [Related]

  • 11. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L, Meyers D, Javorsky G, Burstow D, Lolekha P, Lucas M, Semmler AB, Savarimuthu SM, Fong KM, Yang IA, Atherton J, Galbraith AJ, Parsonage WA, Molenaar P.
    Pharmacogenet Genomics; 2007 Nov 01; 17(11):941-9. PubMed ID: 18075464
    [Abstract] [Full Text] [Related]

  • 12. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.
    O'Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ.
    Clin Sci (Lond); 2000 Sep 01; 99(3):233-8. PubMed ID: 11787477
    [Abstract] [Full Text] [Related]

  • 13. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
    Lemaitre RN, Heckbert SR, Sotoodehnia N, Bis JC, Smith NL, Marciante KD, Hindorff LA, Lange LA, Lumley TS, Rice KM, Wiggins KL, Psaty BM.
    Am J Hypertens; 2008 Mar 01; 21(3):290-6. PubMed ID: 18219297
    [Abstract] [Full Text] [Related]

  • 14. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
    Pascual-Figal DA, Redondo B, Caro C, Manzano S, Garrido IP, Ruipérez JA, Valdés M.
    Am J Cardiol; 2008 Dec 15; 102(12):1711-7. PubMed ID: 19064029
    [Abstract] [Full Text] [Related]

  • 15. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
    Lobmeyer MT, Gong Y, Terra SG, Beitelshees AL, Langaee TY, Pauly DF, Schofield RS, Hamilton KK, Herbert Patterson J, Adams KF, Hill JA, Aranda JM, Johnson JA.
    Pharmacogenet Genomics; 2007 Apr 15; 17(4):277-82. PubMed ID: 17496726
    [Abstract] [Full Text] [Related]

  • 16. Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up.
    Zaugg M, Bestmann L, Wacker J, Lucchinetti E, Boltres A, Schulz C, Hersberger M, Kälin G, Furrer L, Hofer C, Blumenthal S, Müller A, Zollinger A, Spahn DR, Borgeat A.
    Anesthesiology; 2007 Jul 15; 107(1):33-44. PubMed ID: 17585213
    [Abstract] [Full Text] [Related]

  • 17. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients.
    Feringa HH, Bax JJ, Boersma E, Kertai MD, Meij SH, Galal W, Schouten O, Thomson IR, Klootwijk P, van Sambeek MR, Klein J, Poldermans D.
    Circulation; 2006 Jul 04; 114(1 Suppl):I344-9. PubMed ID: 16820598
    [Abstract] [Full Text] [Related]

  • 18. Genetic variants of beta(1)-adrenoceptor gene polymorphisms (Ser49Gly and Arg389Gly) and essential hypertension in a south Indian Tamil population.
    Ramu P, Rajan S, Shewade DG, Swaminathan RP, Dutta TK, Balachander J, Adithan C.
    Clin Exp Pharmacol Physiol; 2009 May 04; 36(5-6):576-82. PubMed ID: 19673943
    [Abstract] [Full Text] [Related]

  • 19. Beta1-adrenergic receptor polymorphisms, QTc interval and occurrence of symptoms in type 1 of long QT syndrome.
    Paavonen KJ, Swan H, Piippo K, Laitinen P, Fodstad H, Sarna S, Toivonen L, Kontula K, Viitasalo M.
    Int J Cardiol; 2007 May 31; 118(2):197-202. PubMed ID: 17023080
    [Abstract] [Full Text] [Related]

  • 20. Beta1-adrenergic receptor gene polymorphisms in Mexican patients with idiopathic dilated cardiomyopathy.
    Fragoso JM, Rodríguez-Pérez JM, González J, Cruz D, Pérez-Méndez O, de Jesus García J, de la Peña A, Arce M, Reyes PA, Vargas-Alarcón G.
    Exp Mol Pathol; 2006 Jun 31; 80(3):279-82. PubMed ID: 16487965
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.